Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company is headquartered in Toronto, Canada.
| Revenue (TTM) | $1.58M |
| Gross Profit (TTM) | 823,000 |
| EBITDA | $-8.38M |
| Operating Margin | -414.40% |
| Return on Equity | -131.50% |
| Return on Assets | -45.70% |
| Revenue/Share (TTM) | $0.11 |
| Book Value | $0.57 |
| Price-to-Book | 3.25 |
| Price-to-Sales (TTM) | 17.20 |
| EV/Revenue | 16.6 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1028.00% |
| Shares Outstanding | $15.57M |
| Float | $13.58M |
| % Insiders | 28.00% |
| % Institutions | 7.88% |